HSA
MED icon

Hussman Strategic Advisors’s Medifast MED Stock Holding History

Hussman Strategic Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,600
Closed -$444K – 351
2022
Q1 		$444K Hold
2,600
– – 0.09% 270
2021
Q4 		$545K Sell
2,600
-3,600
-58% -$744K 0.12% 240
2021
Q3 		$1.19M Hold
6,200
– – 0.26% 148
2021
Q2 		$1.75M Buy
+6,200
New +$1.68M 0.36% 107
2021
Q1 		– Sell
-2,550
Closed -$501K – 351
2020
Q4 		$501K Hold
2,550
– – 0.13% 233
2020
Q3 		$419K Buy
+2,550
New +$420K 0.11% 223

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.46B AUM 71.13% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Hussman Strategic Advisors's MED Position: Q2 2022 in Review

Hussman Strategic Advisors sold out of Medifast (MED) in Q2 2022, closing a stake of 2,600 shares — an estimated $444K sold.

Hussman Strategic Advisors first reported a position in MED in Q3 2020 and held it in 6 quarters. The position peaked at $1.75M in Q2 2021. 284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

  • Hussman Strategic Advisors reported no remaining Medifast position as of Q2 2022 after selling out during the quarter.
  • Hussman Strategic Advisors sold 2,600 Medifast shares in Q2 2022, an estimated $444K.
  • Hussman Strategic Advisors first reported a position in Medifast in Q3 2020 and held it in 6 quarters.
  • Hussman Strategic Advisors's Medifast position peaked at $1.75M in Q2 2021.
  • 284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Hussman Strategic Advisors's 13F filing for Q2 2022, filed 12 Sep 2022.